Participate in an ongoing study
By participating in surveys, interviews, or clinical studies, you contribute directly to research that improves diagnosis, treatment, and long-term outcomes for people living with GBS, CIDP, MMN, and related conditions.
Vitalize: A CIDP Clinical Trial
Canadian CIDP patients are welcome to inquire if they are eligible to participate in the Vitalize clinical study for the treatment of CIDP. The Vitalize study seeks to understand whether the study medicine can improve the symptoms of CIDP and their impact on daily activities.
Participants must be 18+ years of age, have been diagnosed with CIDP, and be receiving a stable dose of immunoglobulins that are helping with disease symptoms but not fully.
Study Pamphlet:
